393 related articles for article (PubMed ID: 18391624)
21. Long-term prognostic effects of plasma epstein-barr virus DNA by minor groove binder-probe real-time quantitative PCR on nasopharyngeal carcinoma patients receiving concurrent chemoradiotherapy.
Lin JC; Wang WY; Liang WM; Chou HY; Jan JS; Jiang RS; Wang JY; Twu CW; Liang KL; Chao J; Shen WC
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1342-8. PubMed ID: 17449194
[TBL] [Abstract][Full Text] [Related]
22. [A comparison of two modalities of complex chemoradiotherapy for locally advanced nasopharyngeal carcinoma].
Alieva SB; Tkachëv SI; Matiakin EG; Kondrat'eva AP; Zimina NA; Sakharovskaia VG; Iachmeneva NF; Romanov IS
Vopr Onkol; 2004; 50(6):701-5. PubMed ID: 15755067
[TBL] [Abstract][Full Text] [Related]
23. Plasma Epstein-Barr viral deoxyribonucleic acid quantitation complements tumor-node-metastasis staging prognostication in nasopharyngeal carcinoma.
Leung SF; Zee B; Ma BB; Hui EP; Mo F; Lai M; Chan KC; Chan LY; Kwan WH; Lo YM; Chan AT
J Clin Oncol; 2006 Dec; 24(34):5414-8. PubMed ID: 17135642
[TBL] [Abstract][Full Text] [Related]
24. Nasopharyngeal carcinoma: alternative treatment options after disease progression.
Arango BA; Castrellon AB; Perez CA; Raez LE; Santos ES
Expert Rev Anticancer Ther; 2010 Mar; 10(3):377-86. PubMed ID: 20214519
[TBL] [Abstract][Full Text] [Related]
25. Controversies and challenges in the current management of nasopharyngeal cancer.
Tham IW; Lu JJ
Expert Rev Anticancer Ther; 2010 Sep; 10(9):1439-50. PubMed ID: 20836679
[TBL] [Abstract][Full Text] [Related]
26. Role of neoadjuvant therapy for esophageal adenocarcinoma.
Ku GY; Ilson DH
Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
[TBL] [Abstract][Full Text] [Related]
27. Staging and treatment of advanced esophageal cancer.
von Rahden BH; Stein HJ
Curr Opin Gastroenterol; 2005 Jul; 21(4):472-7. PubMed ID: 15930991
[TBL] [Abstract][Full Text] [Related]
28. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
[TBL] [Abstract][Full Text] [Related]
29. [Therapeutic effect of medical therapy upon undifferentiated nasopharyngeal carcinoma: analysis of 149 cases].
Chen M; Lin S; Zheng W
Zhonghua Yi Xue Za Zhi; 2001 Dec; 81(24):1488-9. PubMed ID: 16200771
[TBL] [Abstract][Full Text] [Related]
30. The additional value of chemotherapy to radiotherapy in locally advanced nasopharyngeal carcinoma: a meta-analysis of the published literature.
Langendijk JA; Leemans CR; Buter J; Berkhof J; Slotman BJ
J Clin Oncol; 2004 Nov; 22(22):4604-12. PubMed ID: 15542811
[TBL] [Abstract][Full Text] [Related]
31. Update on the management and therapeutic monitoring of advanced nasopharyngeal cancer.
Loong HH; Ma BB; Chan AT
Hematol Oncol Clin North Am; 2008 Dec; 22(6):1267-78, x. PubMed ID: 19010273
[TBL] [Abstract][Full Text] [Related]
32. Chemoradiotherapy for locally recurrent nasopharyngeal carcinoma: treatment outcome and prognostic factors.
Nakamura T; Kodaira T; Tachibana H; Tomita N; Tomoda T; Nakahara R; Inokuchi H; Mizoguchi N; Takada A; Fuwa N
Jpn J Clin Oncol; 2008 Dec; 38(12):803-9. PubMed ID: 18840881
[TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated radiation therapy with simultaneous integrated boost technique following neoadjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Kim K; Wu HG; Kim HJ; Sung MW; Kim KH; Lee SH; Heo DS; Kim HJ; Park CI
Head Neck; 2009 Sep; 31(9):1121-8. PubMed ID: 19340863
[TBL] [Abstract][Full Text] [Related]
34. Combined modality treatment of laryngeal squamous cell carcinoma.
Devlin JG; Langer CJ
Expert Rev Anticancer Ther; 2007 Mar; 7(3):331-50. PubMed ID: 17338653
[TBL] [Abstract][Full Text] [Related]
35. Present status of management of nasopharyngeal carcinoma.
Wei WI; Sham JS
Expert Rev Anticancer Ther; 2001 Jun; 1(1):134-41. PubMed ID: 12113121
[TBL] [Abstract][Full Text] [Related]
36. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma.
Ma BB; Chan AT
Cancer; 2005 Jan; 103(1):22-31. PubMed ID: 15565580
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and therapy in advanced cancer of the esophagus and the gastroesophageal junction.
Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
Curr Opin Gastroenterol; 2006 Jul; 22(4):437-41. PubMed ID: 16760764
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma.
Tan EL; Looi LM; Sam CK
Singapore Med J; 2006 Sep; 47(9):803-7. PubMed ID: 16924363
[TBL] [Abstract][Full Text] [Related]
39. Potential improvement of tumor control probability by induction chemotherapy for advanced nasopharyngeal carcinoma.
Lee AW; Lau KY; Hung WM; Ng WT; Lee MC; Choi CW; Chan CC; Tung R; Cheng PT; Yau TK
Radiother Oncol; 2008 May; 87(2):204-10. PubMed ID: 18329742
[TBL] [Abstract][Full Text] [Related]
40. Adenoid cystic carcinoma of the nasopharynx: 27-year experience.
Liu TR; Yang AK; Guo X; Li QL; Song M; He JH; Wang YH; Guo ZM; Zhang Q; Chen WQ; Chen FJ
Laryngoscope; 2008 Nov; 118(11):1981-8. PubMed ID: 18758378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
